These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1360 related articles for article (PubMed ID: 19646356)

  • 1. New advances in the pathogenesis of ANCA-associated vasculitides.
    Chen M; Kallenberg CG
    Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S108-14. PubMed ID: 19646356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides.
    Kallenberg CG; Heeringa P; Stegeman CA
    Nat Clin Pract Rheumatol; 2006 Dec; 2(12):661-70. PubMed ID: 17133251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Republished: Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
    Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
    Postgrad Med J; 2014 May; 90(1063):290-6. PubMed ID: 24737903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of ANCA-associated vasculitides.
    Kallenberg CG
    Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i59-63. PubMed ID: 21339221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
    Ozaki S
    Allergol Int; 2007 Jun; 56(2):87-96. PubMed ID: 17460438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
    Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
    Ann Rheum Dis; 2013 Aug; 72(8):1273-9. PubMed ID: 23606701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathogenesis of primary systemic vasculitides (I): ANCA-positive vasculitides].
    Guilpain P; Chanseaud Y; Tamby MC; Mahr A; Servettaz A; Guillevin L; Mouthon L
    Presse Med; 2005 Aug; 34(14):1013-22. PubMed ID: 16225257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ANCA-Associated Vasculitis: Core Curriculum 2020.
    Geetha D; Jefferson JA
    Am J Kidney Dis; 2020 Jan; 75(1):124-137. PubMed ID: 31358311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New aspects in ANCA-associated vasculitides].
    Lamprecht P
    Med Klin (Munich); 2004 Sep; 99(9):518-22. PubMed ID: 15372181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of PR3-ANCA associated vasculitis.
    Kallenberg CG
    J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ANCA associated vasculitis (AAV): a review for internists.
    Yaseen K; Mandell BF
    Postgrad Med; 2023 Jan; 135(sup1):3-13. PubMed ID: 35831990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of ANCA-associated vasculitis: new possibilities for intervention.
    Kallenberg CG; Stegeman CA; Abdulahad WH; Heeringa P
    Am J Kidney Dis; 2013 Dec; 62(6):1176-87. PubMed ID: 23810690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-neutrophil cytoplasmic antibody pathogenesis in small-vessel vasculitis: an update.
    Gómez-Puerta JA; Bosch X
    Am J Pathol; 2009 Nov; 175(5):1790-8. PubMed ID: 19815703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
    Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
    Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients.
    Geffriaud-Ricouard C; Noël LH; Chauveau D; Houhou S; Grünfeld JP; Lesavre P
    Clin Nephrol; 1993 Mar; 39(3):125-36. PubMed ID: 7681736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antineutrophil cytoplasmic antibodies].
    Sebastiani GD
    Reumatismo; 2009; 61(1):69-76. PubMed ID: 19370191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies.
    Choi HK; Liu S; Merkel PA; Colditz GA; Niles JL
    J Rheumatol; 2001 Jul; 28(7):1584-90. PubMed ID: 11469466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies.
    Xiao H; Schreiber A; Heeringa P; Falk RJ; Jennette JC
    Am J Pathol; 2007 Jan; 170(1):52-64. PubMed ID: 17200182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis.
    Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):111-118. PubMed ID: 28339364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathophysiology of ANCA-associated vasculitides].
    Mouthon L; Millet A; Régent A; Pederzoli-Ribeil M; Witko-Sarsat V
    Presse Med; 2012 Oct; 41(10):996-1003. PubMed ID: 22921085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 68.